Science & Enterprise subscription

Follow us on Twitter

  • Findings from a Pew Research Center survey released this week show more Americans with smartphones use their phones…
    about 16 hours ago
  • New post on Science and Enterprise: Infographic – Phones Top Internet Access Method #Science #Business
    about 16 hours ago
  • Results from a small-scale clinical trial show an implanted device that stimulates the vagus nerve helps reduce the…
    about 2 days ago
  • New post on Science and Enterprise: Nerve Stimulation Reduces Arthritis Inflammation #Science #Business
    about 2 days ago
  • The Bill and Melinda Gates Foundation is backing research to combine a microscopy technique that grows the size of…
    about 2 days ago

Please share Science & Enterprise

University Developing Wearable Artificial Lung Device

PAAL device prototype (University of Pittsburgh)

PAAL device prototype (University of Pittsburgh)

Biomedical engineers at University of Pittsburgh are developing a portable artificial lung for patients awaiting a transplant, yet still retain their mobility. The project headed by William Federspiel, director of the university’s medical device lab, is funded by a $3.4 million grant from National Institutes of Health.

The device will serve as a bridge for patients with acute or chronic lung failure awaiting a transplant lung or facing an extended recovery. Current artificial lung technologies, such as extracorporeal membrane oxygenation (ECMO), drain blood from the body to restore adequate oxygen levels, and is then returned to the blood stream. The equipment used for ECMO, however, is heavy and unwieldy, even in ambulatory systems.

The Pittsburgh project called the Paracorporeal Ambulatory Assist Lung or PAAL, as described by Federspiel, “is a wearable, fully integrated blood pump and lung designed to provide longer-term respiratory support up to one to three months while maintaining excellent blood compatibility.” This device is expected to complement a wearable artificial pump-lung developed at University of Maryland, but aims to improve on the Maryland device’s transfer of oxygen and carbon dioxide, as well as increase its biocompatibility.

A key objective of the Pittsburgh device is patient mobility. “Our wearable lung will be designed to get patients up and moving within the hospital setting,” says Federspiel, “which is important for both patient recovery and improving a patient’s status prior to a lung transplant.”

Federspiel is a co-founder of a Pittsburgh start-up company Alung Technologies that provides advanced respiratory support systems. Alung developed a respiratory assist device that the company says works like dialysis to remove carbon dioxide and deliver oxygen to the blood. In late February, Alung received CE Mark approval to market the device in Europe.

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.